Ari Bousbib

CEO & Chairman, IQVIA

Search every verified Ari Bousbib interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. During IQVIA's third quarter 2020 earnings call, Ari Bousbib, chairman and chief executive officer, discussed the company's operational recovery from the pandemic. He stated that site accessibility for in-flight trials had returned to about 70% of normal levels, with a focus on the most significant sites, and that patient recruitment, while disrupted, had increased throughout the quarter. Bousbib said he did not expect recruitment to return to baseline levels until sometime in 2021, and noted that this was factored into the company's guidance. Bousbib also provided updates on IQVIA's technology and financial strategies. He reported continued momentum for the company's OCS product, citing 45 new clients since the beginning of the year, bringing the total to over 25 distinct clients, and approximately 63,000 to 65,000 users in deployment. Regarding capital allocation, he said the company had not repurchased shares since suspending its program in the first quarter, but planned to resume opportunistically after the OCS release. He also stated that IQVIA had deliberately avoided workforce restructuring and maintained base compensation, citing a focus on employees and an anticipated strong recovery in the fourth quarter and 2021.